2025 Trends: Organoids
This perspective piece from Genetic Engineering & Biotechnology News discusses the significance of human-relevant models and organoids in drug discovery and R&D in the coming years.
Within, Molecular Devices President Mary Duseau emphasizes the crucial role of automation, AI, and assay-ready patient-derived organoids in ensuring reliable and efficient development of these models.